1. P497 The value of endoscopic healing index monitoring for guiding infliximab dosing in patients with Crohn's disease. (27th May 2021) Authors: Kantasiripitak, W; Mathôt, R; Oldenburg, B; Buisson, A; Ferrante, M; Laharie, D; D'Haens, G; Vermeire, S; Dreesen, E Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P597 Optimising therapeutic drug monitoring of adalimumab with dried blood samples in IBD patients: an interim analysis. (25th January 2019) Authors: Berends, S; Bloem, K; Talwar, R; De Vries, A; Schaap, T; Strik, A; Löwenberg, M; D'Haens, G; Mathôt, R Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P648 Clinical feasibility of dried blood sampling for infliximab in IBD patients. (16th January 2018) Authors: Berends, S; D'Haens, G; Bloem, K; Schaap, J; De Vries, A; Rispens, T; Mathôt, R Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗